<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>37242</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-2121-2-13</infon><infon key="article-id_pmc">37242</infon><infon key="article-id_pmid">11495629</infon><infon key="article-id_publisher-id">1471-2121-2-13</infon><infon key="fpage">13</infon><infon key="journal-title">BMC Cell Biology</infon><infon key="lpage">13</infon><infon key="name_0">surname:Melien;given-names:&#216;yvind</infon><infon key="name_1">surname:Christoffersen;given-names:Thoralf</infon><infon key="name_2">surname:Sioud;given-names:Mouldy</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2</infon><infon key="year">2001</infon><offset>0</offset><text>Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>107</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>118</offset><text>The recent discovery that pertussis toxin (PTX) could play a role in the inhibition of extracellular signal-regulated kinases ERK1 and ERT2 by prostaglandin (PG)F2 by Gi proteins suggests the importance of Gi protein expression.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>328</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>336</offset><text>A particular ribozyme targeted the Gi2 expression and prevented the ERK1/2 activation induced by PGF2 in hepatocytes, but no specific cleaving form of the giant globulin (Gi2+) molecule did so, and neither Gi 2 nor Gq levels were affected in cells treated with ricozyminate thus supporting the specificity of this RNA-sylation of acetyltransferase inhibitor.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>733</offset><text>What is the conclusion?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>744</offset><text>The prevailing evidence indicates that Gi2 plays a crucial role in the activation of PGF2 -mediated ERK1/2 signaling in hepatocytes.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>849</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>862</offset><text>The hypothesis that G-protein-coupled receptors can modulate the activity of extracellular signal-regulated kinases is known to be supported by studies in mice, and the role of G-protein-coupled receptors in the regulation of gene expression in cells has been well established. However, the mechanism of action of G-protein-coupled receptors in the regulation of gene expression remains unclear. Here we report that the activation of extracellular signal-regulated kinases is modulated by G-protein-coupled receptors in hepatocytes, and that G-protein-coupled receptors mediate the action of G-protein-coupled receptors in the regulation of gene expression in hepatocytes.

Materials and Methods:

Hepat</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>1877</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>1885</offset><text>Inhibition of ERK activation by pertussis toxin</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>1933</offset><text>Pretreatment of hepatocytes with pertussis toxin was reported to decrease ERK1/2 activation by agents acting both on heptahelical G protein coupled receptors as well as receptor tyrosine kinases. These observations are summarized in Fig. 1. In addition these data show the persistence with time of the marked inhibitory effect of PTX on ERK1/2 activation induced by PGF2&#945; . The EGF- and HGF-induced responses are on the other hand only partially decreased. These findings suggest that ERK1/2 activation in hepatocytes involve Gi protein(s).</text></passage><passage><infon key="file">1471-2121-2-13-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>2478</offset><text>Effect of pertussis toxin (PTX) on ERK1/2 activation. PTX was added to cultured hepatocytes at 3 h after the time of seeding. A: ERK1/2 activation in the absence or presence of PTX (400 ng/ml) in response to stimulation with PGF2&#945; (10 &#956;M) for 5 min in the period from 8 h to 48 h. B, C: Effect of PTX (300 ng/ml) on ERK1/2 activation in response to stimulation with EGF (10 nM) (B) or HGF (100 ng/ml) (C) for 5 min at 24 and 48 h. D: Time-course for HGF- (100 ng/ml) induced ERK1/2 activation in the absence or presence of PTX (300 ng/ml). Results in A-D represent means &#177; S.E.M. from three experiments.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>3088</offset><text>Ribozyme targeting the Gi2&#945;</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>3120</offset><text>Although the data shown in Fig. 1 suggest that the activation of ERK1/2 implicated Gi, they do not determine the subtype of Gi involved in this process. Accordingly, we have evaluated the effects of a ribozyme specific for Gi2&#945; upon ERK1/2 activation. The choice of target was based on the knowledge of Gi2 as a major member of the Gi family in hepatocytes, which is also represented by Gi3 in these cells, and furthermore on the &#945; subunit as the unifying part of the heterotrimer which additionally comprises &#946;&#947; variants of hitherto unknown subtype compositions and G protein specificity.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>3725</offset><text>Ribozymes are RNA molecules that specifically cleave mRNAs. These molecules have been shown to inhibit gene expression in various cell types. To increase the ribozyme stabililty, all hydroxyl pyrimidines were replaced by their 2'-amino analogs. This type of modification was shown to enhance the ribozyme stability without affecting its cleavage activity. Fig. 2A shows the cleavage of the RNA substrate by the ribozyme.</text></passage><passage><infon key="file">1471-2121-2-13-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4146</offset><text>Gi2&#945; ribozyme. A: Ribozyme in vitro cleavage activity. A PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA) printout of a 15 % polyacrylamide gel with 7 M urea. The 5'-end-labelled RNA substrate (200 nM) was incubated with the ribozyme (75 nM) in reaction buffer as described in Materials and Methods. 10 &#956;l samples were taken at the indicated time, added to 5 &#956;l quenching solution and then analysed by electrophoresis. The arrow indicates cleavage products. B: Ribozyme uptake in cultured hepatocytes. Hepatocytes were transfected with 5'-FITC-labelled ribozyme for 30 h. Following washing with phosphate-buffered saline (PBS), cells were analysed by fluorescence microscopy.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4835</offset><text>Several approaches have been explored in order to introduce genes into hepatocytes. As a first step, we have examined the usefulness of the cationic lipid-mediated ribozyme delivery into hepatocytes. In this respect, the hepatocytes were transfected with a 5'-carboxyfluorescein-conjugated ribozyme and analysed by fluorescence (Fig. 2B). As shown, most cells had taken the ribozyme molecules. Furthermore, no significant cytotoxic effect was observed at the concentration used. Thus DOTAP may represent a versatile transfection reagent for primary hepatocytes.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5397</offset><text>Inhibition of Gi2&#945; expression and ERK1/2 activation by ribozyme treatment</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5475</offset><text>Having demonstrated a cellular uptake of ribozymes into cultured hepatocytes when DOTAP was used as delivery agent, in the next set of experiments we examined the effects of the Gi2&#945; ribozyme on Gi2&#945; protein levels as well as on the total ERK1/2 expression and activation. DOTAP formulated test molecules were added to the hepatocyte cultures at 4&#8211;5 hours after the time of seeding. After 30&#8211;45 hours transfection time the expression of Gi2&#945; protein was decreased in ribozyme-treated cells, while no significant effect was seen with its non-cleaving form (Fig. 3A). The expression of Gq&#945; (Fig. 3B) or Gs&#945; (not shown) was not affected by the ribozyme treatment thus confirming the specificity of the ribozyme effects upon Gi2&#945; gene expression. To investigate the functional roles of Gi2 on ERK1/2 activation, we examined the phosphorylation of ERK1/2 in ribozyme-treated cells following PGF2&#945; stimulation (Fig. 3C, D). The basal level of ERK1/2 phosphorylation (i.e. in the absence PGF2&#945; stimulation) was not reduced following ribozyme treatment (Fig. 3C). However, the PGF2&#945;-induced phosphorylation of ERK1/2 was decreased (Fig. 3C and 3D, lower panel). In contrast, the total ERK1/2 protein level was not affected by the treatment (Fig. 3D, upper panel). To further confirm the decrease in ERK1/2 phosphorylation, we also assessed their activity in response to PGF2&#945; stimulation (Fig. 4). A marked inhibitory effect was found in ribozyme-treated cells. The activation of ERK1/2 by EGF was, however, reduced to a lesser extent. These results also show the absence of inhibition by the non-cleaving form of the Gi2&#945; ribozyme.</text></passage><passage><infon key="file">1471-2121-2-13-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7144</offset><text>Western analysis of the effects of ribozyme on Gi2&#945; and ERK1/2. Gi2&#945; ribozyme (Rz) or non-cleaving Gi2&#945; ribozyme (Rzm) complexed with DOTAP giving final ribozyme concentrations of 2.5 &#956;M, or only DOTAP (Ctr) were added to hepatocyte cultures at 4&#8211;5 hours after the time of seeding. A: Expression of Gi2&#945; protein was assessed after 45 h of ribozyme treatment using antibody (from Calbiochem) directed against C-terminal end of Gi1/i2&#945; . B: Expression of Gi2&#945; and Gq&#945; protein levels in the same samples subsequent to 30 h of ribozyme treatment using antibodies (from NEN&#8482; Life Science Products) against C-terminal sequences of Gi1/i2&#945; or Gq&#945;, respectively. The polyclonal antibodies used to assess Gi2&#945; recognize both the &#945; subunit of Gi2 and Gi1. As shown previously hepatocytes do not express Gi1&#945;, so the reactivity with these antibodies reflects only the Gi2&#945; levels. C, D: After 45 h of ribozyme treatment cells were stimulated with or without PGF2&#945; (10 &#956;M) for 5 min before they were harvested. Immunoblot using antibody against dually phosphorylated ERK1/2 (i.e. ERK1/2-P) (C) is depicted. In Fig. D is developed images from the same immunoblot using antibody detecting total amount of ERK1/2 (i.e. both phosphorylated and unphosphorylated forms) (upper panel) and antibody against dually phosphorylated fractions of ERK1/2 (lower panel).</text></passage><passage><infon key="file">1471-2121-2-13-4.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8546</offset><text>Effect of Gi2&#945; ribozyme on ERK1/2 activation. Gi2&#945; ribozyme (Rz) or non-cleaving Gi2&#945; ribozyme (Rzm) complexed with DOTAP giving final ribozyme concentrations of 2.5 &#956;M, or DOTAP without ribozyme, were added to hepatocyte cultures at 4&#8211;5 hours after the time of seeding. After 30 h of treatment the cell cultures were stimulated with PGF2&#945; (10 &#956;M) or EGF (10 nM) for 5 min before they were harvested and ERK1/2 activity assessed. Results are expressed as percent of untreated control and represent mean &#177; S.E.M. from three experiments.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>9101</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9112</offset><text>In the current study we have investigated the role of Gi2&#945; upon PGF2&#945; -induced ERK1/2 activation in hepatocytes. The data obtained with the ribozyme suggest that Gi2 is an important factor in ERK1/2 activation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9331</offset><text>Gi proteins are believed to be involved in regulation of cell growth, and a role in activation of ERK1/2 is reported in different cells. In hepatocytes it has been observed that PTX inhibited activation of ERK1/2 both by agents acting on G protein coupled receptors including vasopressin, angiotensin II, norepinephrine and PGF2&#945; as well as by agents that bind to receptor tyrosine kinases like EGF and HGF, also suggesting roles of Gi. In the present study we explored closer the Gi dependency of PGF2&#945; -induced ERK1/2 activation, which is strongly PTX-sensitive. We used a ribozyme approach, which has been examined in a variety of experimental models to suppress gene expression, including in human hepatocytes and hepatoma cells. Notably, ribozymes were recently reported to effectively suppress the expression of the &#947;7 subunit of heterotrimeric G proteins in HEK 293 cells.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10223</offset><text>Pretreatment of the hepatocytes with the Gi2&#945; ribozyme resulted in a marked inhibition of the PGF2&#945; -induced ERK1/2 activation. The findings might be explained by the ability of PGF2&#945; to act through receptors that couple directly to Gi in these cells. In addition, the Gi2&#945; ribozyme resulted in a partial decrease of the EGF-induced ERK1/2 activation, in accordance with a role of Gi. However, the explanation for an involvement of Gi in this pathway is not known. Observations in different cell types have indicated that Gi might play a role in EGF-induced cell signaling, and in hepatocytes a direct coupling of the EGF receptor to Gi has been proposed. One explanation is that receptor-independent functions of Gi may be involved in signaling from receptor tyrosine kinases as well as from seven transmembrane receptors. Since cyclic AMP was found to exert a negative control of ERK1/2 activation in hepatocytes, it can be speculated that the decreases in ERK1/2 responses observed subsequent to inhibition of Gi function might be caused by an elevation of intracellular levels of cyclic AMP. However, in experiments using pertussis toxin there were no detectable alterations of the cyclic AMP level under basal conditions (data not shown). Furthermore, as shown in the present study ribozyme treatment of the hepatocytes did not decrease the basal ERK1/2 activation thus suggesting no significant alteration of cyclic AMP level under these experimental conditions.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11708</offset><text>The present data show a close correlation between the inhibitory effect on ERK1/2 activation produced by the Gi2&#945; ribozyme compared to the effects obtained with PTX. This suggests that the PTX effects that have been observed, at least on ERK1/2 activation in response to PGF2&#945; as well as EGF stimulation, reflect Gi2-mediated mechanisms. However, the present data do not rule out a possible contribution of Gi3 in ERK1/2 activation. In this regard, it is of note that observations in endothelial cells have suggested a role for Gi2 proteins, but not Gi3, in ERK1/2 activation. Further studies involving specific inhibition of Gi3 proteins will be needed to clarify this issue in the hepatocyte model.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12417</offset><text>Previous findings have demonstrated that Gi dependent activations of ERK1/2 are mediated through &#946;&#947; subunits. These results were derived from studies where ERK activation was elicited by overexpression of &#946;&#947;, or antagonized by the &#946;&#947;-inhibitory peptide &#946;1ct (C-terminal fragment of the &#946;-adrenergic receptor kinase-1). Although a possible role for &#946;&#947; in ERK1/2 activation can not be ruled out, the present data might be compatible with a role for the &#945; i2 subunit. This interpretation agrees with observations reported by Hedin et al. who found that in Jurkat T lymphocytes the &#948;-opioid activation of ERK1/2 was PTX-sensitive, but unaffected by &#946;1ct treatment, suggesting an involvement of &#945;i. However, it should be noted that a strategy based on targeting a particular subunit of a G protein might affect the overall function of the heterotrimer.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>13314</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>13325</offset><text>Despite the fact that the current study provides additional evidence for the involvement of Gi proteins in ERK1/2 activation in liver, the data cannot exclude the possibility of an active role of G3 in these processes or provide a precise definition of their function. The fact remains that primary hepatocytes are highly transfected with ribozymes may facilitate studies of cell signaling in this model system which represents features of normal cells. Therefore, it is interesting to investigate the roles of different heterotrimeric G proteins and their subunits in activating other mitogen-activated protein</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>14060</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14082</offset><text>Materials</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14092</offset><text>Dulbecco's modified Eagle's medium, Waymouth's medium MAB 87/3, penicillin and streptomycin were from Gibco, Grand Island, NY, U.S.A. Adenosine 5'-triphosphate, collagen, collagenase, phenylmethylsulfonyl fluoride, benzamidine, leupeptin, pepstatin A, myelin basic protein (MBP), epidermal growth factor, prostaglandin F2&#945;, insulin, pertussis toxin, and 2-mercaptoethanol were from Sigma, St. Louis, MO, USA. Hepatocyte growth factor (human) was a gift from Magne B&#248;rset, NTNU, Trondheim, Norway. Sodium(meta)vanadate was from Fluka Chemie AG, Buchs, Switzerland. Phenyl Sepharose CL-4B was from Pharmacia Biotech., Uppsala, Sweden. Dexamethasone was from Norwegian Medicinal Depot, Oslo, Norway. DOTAP was from Boehringer Mannheim, Mannheim, Germany. T7 RNA polymerase and T4 polynucleotide kinase were from Promega Corporation, Madison, WI, USA. [&#947;-32 P] Adenosine 5'-triphosphate (3000 Ci/mol) was from Amersham International, Buckinghamshire, England.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15056</offset><text>Isolation and culture of hepatocytes</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15093</offset><text>Male Wistar rats (170&#8211;220 g) fed ad libitum were used. Parenchymal liver cells were isolated by in vitro collagenase perfusion and low-speed centrifugation with modifications. Cell viability, measured as the ability to exclude trypan blue, was at least 95 %. The cells were suspended in culture medium and plated in Costar wells at 20.000 cells/cm2. The culture medium (0.2 ml/cm2) was a 1:1 mixture of Dulbecco's modified Eagle's medium and Waymouth's medium MAB 87/3 containing 16.8 mM glucose, supplemented with penicillin (100 U/ml), streptomycin (0.1 mg/ml), dexamethasone (25 nM) and insulin (100 nM). The cultures were gassed with 95 % air 5% CO2 and kept at 37&#176;C.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15768</offset><text>Measurement of ERK activity</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15796</offset><text>The measurement of ERK1/2 activity was performed as previously described. In brief, the hepatocyte cultures were exposed to agonists for 5 minutes before rinsing the cells and scraping them into a buffer containing 10 % ethylene glycol. The lysate was centrifugated (15,800 &#215; g) for 10 minutes and the supernatant mixed with phenyl-Sepharose, which was washed twice in a 10 %, twice in a 35 % ethylene glycol buffer, before finally eluting ERK1/2 with 60 % ethylene glycol buffer. The eluate was assayed for ERK1/2 activity, using MBP as substrate, in the presence of an inhibitor of protein kinase A (Sigma P-0300). The reaction mixture was spotted onto P81 paper (Whatman, Maidstone, UK), which was washed, dried and counted in a liquid scintillation counter. Protein content was determined with the BCA Protein Assay (Pierce, Rockford, IL, U.S.A.).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>16649</offset><text>Immunoblotting</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16664</offset><text>Aliquots with 20 &#956;g cell protein (total cell lysate prepared in Laemmli buffer) were electrophoresed on 10 % polyacrylamide gels (acrylamide:N'N'-bis-methylene acrylamide 30:0.8) followed by protein electrotransfer to nitrocellulose membranes and immunoblotting with a polyclonal MAP kinase antibody against the dually threonine- and tyrosine phosphorylated forms of ERK1 (p44mapk) and ERK2 (p42mapk) or an antibody detecting both the phosphorylated and unphosphorylated forms (Promega Corporation, Madison, WI, USA). Antibodies against &#945;-subunits of Gi1/i2 were from Calbiochem (La Jolla, CA, USA) and NEN&#8482; Life Science Products (Boston, MA, USA). Antibody against the &#945;-subunit of Gq was from NEN&#8482; Life Science Products (Boston, MA, USA). Immunoreactive bands were visualised with ECL Western blotting detection reagents (Amersham International).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>17522</offset><text>In vitro RNA synthesis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17545</offset><text>A 2'-amino pyrimidine modified hammerhead ribozyme having GUC as cleavage triplet corresponding to the nucleotide number 481 within the rat Gi2&#945; mRNA was synthesized by in vitro transcription using a short DNA template for the T7 RNA polymerase as previously described. Subsequent to transcription ribozymes were PAGE gel-purified, ethanol-precipitated and then dissolved in water. The concentration was determined by assessment of absorbency at 260 nm. A non-cleaving form of the ribozyme was made by deleting the G12 from the catalytic core as indicated by lower case letter. The ribozyme short target was synthesized by in vitro transcription of a synthetic DNA template with the T7 RNA polymerase. Subsequent to transcription, the gel-purified RNA was dephosphorylated by alkaline phosphate and then 5'-end labelled using T4 polynucleotide kinase and [&#947;-32 P]ATP. The ribozyme sequence is: 5'GGCAGCACAGCU GAUGAGUCCGUGAGGACgAAACAGUGCGAACAGC3'. The sequence of the targeted site is: 5'GCUGUUCGCACUGUCCUGUGCUGCC3'. The cleavage site is underlined.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>18602</offset><text>In vitro cleavage activity of the Gi2&#945; ribozyme</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>18654</offset><text>Cleavage reactions were performed at 37&#176;C in a buffer containing 50 mM Tris-HCl (pH 7.4) and 10 mM MgCl2. Cleavage products were separated by electrophoresis on a 15 % polyacrylamide gel containing 7 M urea.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>18863</offset><text>Transfection experiments</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>18888</offset><text>Cells were transfected with DOTAP- (25 &#956;g/ml) formulated ribozyme 4&#8211;5 h after the time of plating. Only single transfections were used giving a ribozyme concentration in the culture medium of 2.5 &#956;M. After 30&#8211;45 hours transfection time, immunoblotting experiments and assessment of ERK1/2 activity were performed.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title_1</infon><offset>19208</offset><text>List of abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>19230</offset><text>Cyclic AMP, Adenosine 3',5'-cyclic monophosphate, DOTAP, N- [1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl ammonium-methylsulphate; EGF, epidermal growth factor; ERK1/2, extracellular signal-regulated kinase 1 and 2; G protein, guanine nucleotide binding (regulatory) protein; GPCR, G protein-coupled receptor; HGF, hepatocyte growth factor; MBP, myelin basic protein; PTX, pertussis toxin; PGF2&#945;, prostaglandin F2&#945;; RTK, receptor tyrosine kinase; Rz, ribozyme; Rzm, mutant ribozyme.</text></passage><passage><infon key="fpage">49</infon><infon key="lpage">139</infon><infon key="name_0">surname:Lewis;given-names:TS</infon><infon key="name_1">surname:Shapiro;given-names:PS</infon><infon key="name_2">surname:Ahn;given-names:NG</infon><infon key="pub-id_pmid">9561267</infon><infon key="section_type">REF</infon><infon key="source">Adv Cancer Res</infon><infon key="type">ref</infon><infon key="volume">74</infon><infon key="year">1998</infon><offset>19719</offset><text>Signal transduction through MAP kinase cascades.</text></passage><passage><infon key="fpage">143</infon><infon key="lpage">180</infon><infon key="name_0">surname:Widmann;given-names:C</infon><infon key="name_1">surname:Gibson;given-names:S</infon><infon key="name_2">surname:Jarpe;given-names:MB</infon><infon key="name_3">surname:Johnson;given-names:GL</infon><infon key="pub-id_pmid">9922370</infon><infon key="section_type">REF</infon><infon key="source">Physiol Rev</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">1999</infon><offset>19768</offset><text>Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.</text></passage><passage><infon key="fpage">1244</infon><infon key="lpage">1253</infon><infon key="name_0">surname:Adachi;given-names:T</infon><infon key="name_1">surname:Nakshima;given-names:S</infon><infon key="name_2">surname:Saji;given-names:S</infon><infon key="name_3">surname:Nakamura;given-names:T</infon><infon key="name_4">surname:Nozawa;given-names:Y</infon><infon key="pub-id_pmid">8621160</infon><infon key="section_type">REF</infon><infon key="source">Hepatology</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1996</infon><offset>19861</offset><text>Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: involvement of protein tyrosine kinase and protein kinase C.</text></passage><passage><infon key="fpage">3556</infon><infon key="lpage">3565</infon><infon key="name_0">surname:Spector;given-names:MS</infon><infon key="name_1">surname:Auer;given-names:KL</infon><infon key="name_2">surname:Jarvis;given-names:WD</infon><infon key="name_3">surname:Ishac;given-names:EJ</infon><infon key="name_4">surname:Gao;given-names:B</infon><infon key="name_5">surname:Kunos;given-names:G</infon><infon key="name_6">surname:Dent;given-names:P</infon><infon key="pub-id_pmid">9199291</infon><infon key="section_type">REF</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1997</infon><offset>20022</offset><text>Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes.</text></passage><passage><infon key="fpage">10</infon><infon key="lpage">18</infon><infon key="name_0">surname:Thoresen;given-names:GH</infon><infon key="name_1">surname:Guren;given-names:TK</infon><infon key="name_2">surname:Sandnes;given-names:D</infon><infon key="name_3">surname:Peak;given-names:M</infon><infon key="name_4">surname:Agius;given-names:L</infon><infon key="name_5">surname:Christoffersen;given-names:T</infon><infon key="pub-id_doi">10.1002/(SICI)1097-4652(199804)175:1&lt;10::AID-JCP2&gt;3.0.CO;2-F</infon><infon key="pub-id_pmid">9491776</infon><infon key="section_type">REF</infon><infon key="source">J Cell Physiol</infon><infon key="type">ref</infon><infon key="volume">175</infon><infon key="year">1998</infon><offset>20200</offset><text>Response to transforming growth factor alfa (TGF&#945;) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGF&#945; is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis.</text></passage><passage><infon key="fpage">348</infon><infon key="lpage">358</infon><infon key="name_0">surname:Melien;given-names:&#216;</infon><infon key="name_1">surname:Thoresen;given-names:GH</infon><infon key="name_2">surname:Sandnes;given-names:D</infon><infon key="name_3">surname:&#216;stby;given-names:E</infon><infon key="name_4">surname:Christoffersen;given-names:T</infon><infon key="pub-id_doi">10.1002/(SICI)1097-4652(199806)175:3&lt;348::AID-JCP13&gt;3.0.CO;2-1</infon><infon key="pub-id_pmid">9572480</infon><infon key="section_type">REF</infon><infon key="source">J Cell Physiol</infon><infon key="type">ref</infon><infon key="volume">175</infon><infon key="year">1998</infon><offset>20488</offset><text>Activation of p42/p44 mitogen- activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2&#945; in hepatocytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin-sensitive mechanisms.</text></passage><passage><infon key="fpage">1167</infon><infon key="lpage">1173</infon><infon key="name_0">surname:Gin&#232;s;given-names:P</infon><infon key="name_1">surname:Li;given-names:X</infon><infon key="name_2">surname:Brown;given-names:SES</infon><infon key="name_3">surname:Nakamura;given-names:T</infon><infon key="name_4">surname:Guzelian;given-names:PS</infon><infon key="name_5">surname:Heasley;given-names:LE</infon><infon key="name_6">surname:Schrier;given-names:RW</infon><infon key="name_7">surname:Nemenoff;given-names:RA</infon><infon key="pub-id_pmid">8621150</infon><infon key="section_type">REF</infon><infon key="source">Hepatology</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1996</infon><offset>20750</offset><text>Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes.</text></passage><passage><infon key="fpage">295</infon><infon key="lpage">300</infon><infon key="name_0">surname:Adachi;given-names:T</infon><infon key="name_1">surname:Nakashima;given-names:S</infon><infon key="name_2">surname:Saji;given-names:S</infon><infon key="name_3">surname:Nakamura;given-names:T</infon><infon key="name_4">surname:Nozawa;given-names:Y</infon><infon key="pub-id_pmid">9252137</infon><infon key="section_type">REF</infon><infon key="source">Hepatology</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">1997</infon><offset>20964</offset><text>Possible involvement of pertussis toxin-sensitive G protein in hepatocyte growth factor-induced signal transduction in cultured rat hepatocytes: pertussis toxin treatment inhibits activation of phospholipid signaling, calcium oscillation, and mitogen-activated protein kinase.</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">36</infon><infon key="name_0">surname:Melien;given-names:&#216;</infon><infon key="name_1">surname:Sandnes;given-names:D</infon><infon key="name_2">surname:Johansen;given-names:EJ</infon><infon key="name_3">surname:Christoffersen;given-names:T</infon><infon key="pub-id_doi">10.1002/(SICI)1097-4652(200007)184:1&lt;27::AID-JCP3&gt;3.0.CO;2-Q</infon><infon key="pub-id_pmid">10825231</infon><infon key="section_type">REF</infon><infon key="source">J Cell Physiol</infon><infon key="type">ref</infon><infon key="volume">184</infon><infon key="year">2000</infon><offset>21241</offset><text>Effects of pertussis toxin on ERK activation in hepatocytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of Gi proteins at a level distal to receptor coupling.</text></passage><passage><infon key="fpage">585</infon><infon key="lpage">591</infon><infon key="name_0">surname:Hasseloff;given-names:J</infon><infon key="name_1">surname:Gerlach;given-names:WL</infon><infon key="pub-id_doi">10.1038/334585a0</infon><infon key="pub-id_pmid">2457170</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">334</infon><infon key="year">1988</infon><offset>21440</offset><text>Simple RNA enzymes with new and highly specific endoribonuclease activities.</text></passage><passage><infon key="fpage">301</infon><infon key="lpage">306</infon><infon key="name_0">surname:Rossi;given-names:JJ</infon><infon key="pub-id_doi">10.1016/S0167-7799(00)88969-6</infon><infon key="section_type">REF</infon><infon key="source">Trends Biotech</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1995</infon><offset>21517</offset><text>Controlled, targeted, intracellular expression of ribozymes: progress and problems.</text></passage><passage><infon key="fpage">3319</infon><infon key="lpage">3326</infon><infon key="name_0">surname:Murayama;given-names:T</infon><infon key="name_1">surname:Ui;given-names:M</infon><infon key="pub-id_pmid">6298231</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">258</infon><infon key="year">1983</infon><offset>21601</offset><text>Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes.</text></passage><passage><infon key="fpage">449</infon><infon key="lpage">457</infon><infon key="name_0">surname:Bushfield;given-names:M</infon><infon key="name_1">surname:Murphy;given-names:GJ</infon><infon key="name_2">surname:Lavan;given-names:BE</infon><infon key="name_3">surname:Parker;given-names:PJ</infon><infon key="name_4">surname:Hruby;given-names:VJ</infon><infon key="name_5">surname:Milligan;given-names:G</infon><infon key="name_6">surname:Houslay;given-names:MD</infon><infon key="pub-id_pmid">2114093</infon><infon key="section_type">REF</infon><infon key="source">Biochem J</infon><infon key="type">ref</infon><infon key="volume">268</infon><infon key="year">1990</infon><offset>21799</offset><text>Diabetes- induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine-nucleotide-binding regulatory protein Gi2.</text></passage><passage><infon key="fpage">334</infon><infon key="lpage">341</infon><infon key="name_0">surname:Cadrin;given-names:M</infon><infon key="name_1">surname:McFarlane-Anderson;given-names:N</infon><infon key="name_2">surname:Harper;given-names:ME</infon><infon key="name_3">surname:Gaffield;given-names:J</infon><infon key="name_4">surname:Begin-Heick;given-names:N</infon><infon key="pub-id_doi">10.1002/(SICI)1097-4644(199609)62:3&lt;334::AID-JCB4&gt;3.0.CO;2-S</infon><infon key="pub-id_pmid">8872605</infon><infon key="section_type">REF</infon><infon key="source">J Cell Biochem</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">1996</infon><offset>21955</offset><text>Comparison of the subcellular distribution of G-proteins in hepatocytes in situ and in primary cultures.</text></passage><passage><infon key="fpage">556</infon><infon key="lpage">561</infon><infon key="name_0">surname:Sioud;given-names:M</infon><infon key="name_1">surname:S&#248;rensen;given-names:D</infon><infon key="pub-id_pmid">9624687</infon><infon key="section_type">REF</infon><infon key="source">Nature Biotech</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1998</infon><offset>22060</offset><text>A nuclease-resistant protein kinase C&#945; ribozyme blocks glioma cell growth.</text></passage><passage><infon key="fpage">381</infon><infon key="lpage">384</infon><infon key="name_0">surname:Sioud;given-names:M</infon><infon key="pub-id_pmid">10085409</infon><infon key="section_type">REF</infon><infon key="source">Int J Mol</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">1999</infon><offset>22139</offset><text>Application of preformed hammerhead ribozymes in the gene therapy of cancer.</text></passage><passage><infon key="fpage">171</infon><infon key="lpage">174</infon><infon key="name_0">surname:Leirdal;given-names:M</infon><infon key="name_1">surname:Sioud;given-names:M</infon><infon key="pub-id_doi">10.1006/bbrc.1998.9286</infon><infon key="pub-id_pmid">9735351</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">250</infon><infon key="year">1998</infon><offset>22216</offset><text>High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification.</text></passage><passage><infon key="fpage">147</infon><infon key="lpage">151</infon><infon key="name_0">surname:Paquereau;given-names:L</infon><infon key="name_1">surname:Le Cam;given-names:A</infon><infon key="pub-id_pmid">1514680</infon><infon key="section_type">REF</infon><infon key="source">Anal Biochem</infon><infon key="type">ref</infon><infon key="volume">204</infon><infon key="year">1992</infon><offset>22326</offset><text>Electroporation-mediated gene transfer into hepatocytes: preservation of a growth hormone response.</text></passage><passage><infon key="fpage">10099</infon><infon key="lpage">10103</infon><infon key="name_0">surname:Hofmann;given-names:C</infon><infon key="name_1">surname:Sandig;given-names:V</infon><infon key="name_2">surname:Jennings;given-names:G</infon><infon key="name_3">surname:Rudolph;given-names:M</infon><infon key="name_4">surname:Schlag;given-names:P</infon><infon key="name_5">surname:Strauss;given-names:M</infon><infon key="pub-id_pmid">7479733</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">1995</infon><offset>22426</offset><text>Efficient gene transfer into human hepatocytes by baculovirus vectors.</text></passage><passage><infon key="fpage">109</infon><infon key="lpage">117</infon><infon key="name_0">surname:Dhanasekaran;given-names:N</infon><infon key="name_1">surname:Prasad;given-names:MV</infon><infon key="pub-id_doi">10.1159/000014536</infon><infon key="pub-id_pmid">9629462</infon><infon key="section_type">REF</infon><infon key="source">Biol Signals Recept</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">1998</infon><offset>22497</offset><text>G protein subunits and cell proliferation.</text></passage><passage><infon key="fpage">22235</infon><infon key="lpage">22238</infon><infon key="name_0">surname:Alblas;given-names:J</infon><infon key="name_1">surname:van Corven;given-names:EJ</infon><infon key="name_2">surname:Hordijk;given-names:PL</infon><infon key="name_3">surname:Milligan;given-names:G</infon><infon key="name_4">surname:Moolenaar;given-names:WH</infon><infon key="pub-id_pmid">8226727</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">268</infon><infon key="year">1993</infon><offset>22540</offset><text>Gi-mediated activation of the p21ras-mitogen-activated protein kinase pathway by &#945;2-adrenergic receptors expressed in fibroblasts.</text></passage><passage><infon key="fpage">1685</infon><infon key="lpage">1695</infon><infon key="name_0">surname:Pace;given-names:AM</infon><infon key="name_1">surname:Faure;given-names:M</infon><infon key="name_2">surname:Bourne;given-names:HR</infon><infon key="pub-id_pmid">8590798</infon><infon key="section_type">REF</infon><infon key="source">Mol BiolCell</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1995</infon><offset>22675</offset><text>Gi2-mediated activation of the MAP kinase cascade.</text></passage><passage><infon key="fpage">1331</infon><infon key="lpage">1342</infon><infon key="name_0">surname:Gutkind;given-names:JS</infon><infon key="pub-id_doi">10.1038/sj.onc.1202186</infon><infon key="pub-id_pmid">9779981</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1998</infon><offset>22726</offset><text>Cell growth control by G protein-coupled receptors: from signal transduction to signal integration.</text></passage><passage><infon key="fpage">7303</infon><infon key="lpage">7307</infon><infon key="name_0">surname:Sioud;given-names:M</infon><infon key="name_1">surname:Drlica;given-names:K</infon><infon key="section_type">REF</infon><infon key="source">Proc Acad Natl Sci</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">1991</infon><offset>22826</offset><text>Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme.</text></passage><passage><infon key="fpage">759</infon><infon key="lpage">765</infon><infon key="name_0">surname:Kim;given-names:YK</infon><infon key="name_1">surname:Junn;given-names:E</infon><infon key="name_2">surname:Park;given-names:I</infon><infon key="name_3">surname:Lee;given-names:Y</infon><infon key="name_4">surname:Kang;given-names:C</infon><infon key="name_5">surname:Ahn;given-names:JK</infon><infon key="pub-id_doi">10.1006/bbrc.1999.0537</infon><infon key="pub-id_pmid">10208856</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res</infon><infon key="type">ref</infon><infon key="volume">257</infon><infon key="year">1999</infon><offset>22932</offset><text>Repression of hepatitis B virus X gene expression by hammerhead ribozymes.</text></passage><passage><infon key="fpage">53</infon><infon key="lpage">60</infon><infon key="name_0">surname:Ozaki;given-names:I</infon><infon key="name_1">surname:Zern;given-names:MA</infon><infon key="name_2">surname:Liu;given-names:S</infon><infon key="name_3">surname:Wei;given-names:DL</infon><infon key="name_4">surname:Pomerantz;given-names:RJ</infon><infon key="name_5">surname:Duan;given-names:L</infon><infon key="pub-id_doi">10.1016/S0168-8278(99)80163-9</infon><infon key="pub-id_pmid">10424283</infon><infon key="section_type">REF</infon><infon key="source">J Hepatol</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1999</infon><offset>23007</offset><text>Ribozyme-mediated specific gene replacement of the &#945;1-antitrypsin gene in human hepatoma cells.</text></passage><passage><infon key="fpage">114</infon><infon key="lpage">120</infon><infon key="name_0">surname:Zern;given-names:MA</infon><infon key="name_1">surname:Ozaki;given-names:I</infon><infon key="name_2">surname:Duan;given-names:L</infon><infon key="name_3">surname:Pomerantz;given-names:R</infon><infon key="name_4">surname:Liu;given-names:SL</infon><infon key="name_5">surname:Strayer;given-names:DS</infon><infon key="pub-id_doi">10.1038/sj.gt.3300793</infon><infon key="pub-id_pmid">10341883</infon><infon key="section_type">REF</infon><infon key="source">Gene Ther</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1999</infon><offset>23107</offset><text>A novel SV40-based vector successfully transduces and expresses an alpha1-antitrypsin ribozyme in a human hepatoma-derived cell line.</text></passage><passage><infon key="fpage">26040</infon><infon key="lpage">26048</infon><infon key="name_0">surname:Wang;given-names:Q</infon><infon key="name_1">surname:Mullah;given-names:B</infon><infon key="name_2">surname:Hansen;given-names:C</infon><infon key="name_3">surname:Asundi;given-names:J</infon><infon key="name_4">surname:Robishaw;given-names:JD</infon><infon key="pub-id_doi">10.1074/jbc.272.41.26040</infon><infon key="pub-id_pmid">9325341</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">272</infon><infon key="year">1997</infon><offset>23241</offset><text>Ribozyme-mediated suppression of the G protein &#947;7 subunit suggests a role in hormone regulation of adenylyl cyclase activity.</text></passage><passage><infon key="fpage">17365</infon><infon key="lpage">17371</infon><infon key="name_0">surname:Wang;given-names:Q</infon><infon key="name_1">surname:Mullah;given-names:BK</infon><infon key="name_2">surname:Robishaw;given-names:JD</infon><infon key="pub-id_doi">10.1074/jbc.274.24.17365</infon><infon key="pub-id_pmid">10358098</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">274</infon><infon key="year">1999</infon><offset>23371</offset><text>Ribozyme approach identifies a functional association between the G protein &#946;1&#947;7 subunits in the &#946;-adrenergic receptor signaling pathway.</text></passage><passage><infon key="fpage">293</infon><infon key="lpage">297</infon><infon key="name_0">surname:Melien;given-names:&#216;</infon><infon key="name_1">surname:Winsnes;given-names:R</infon><infon key="name_2">surname:Refsnes;given-names:M</infon><infon key="name_3">surname:Gladhaug;given-names:IP</infon><infon key="name_4">surname:Christoffersen;given-names:T</infon><infon key="pub-id_pmid">2832160</infon><infon key="section_type">REF</infon><infon key="source">Eur J Biochem</infon><infon key="type">ref</infon><infon key="volume">172</infon><infon key="year">1988</infon><offset>23519</offset><text>Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2&#945; on hormone-induced cAMP accumulation in cultured hepatocytes.</text></passage><passage><infon key="fpage">303</infon><infon key="lpage">311</infon><infon key="name_0">surname:Ram&#237;rez;given-names:I</infon><infon key="name_1">surname:Tebar;given-names:F</infon><infon key="name_2">surname:Grau;given-names:M</infon><infon key="name_3">surname:Soley;given-names:M</infon><infon key="pub-id_doi">10.1016/0898-6568(95)00001-6</infon><infon key="pub-id_pmid">8527298</infon><infon key="section_type">REF</infon><infon key="source">Cell Signal</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">1995</infon><offset>23671</offset><text>Role of heterotrimeric G proteins in epidermal growth factor signalling.</text></passage><passage><infon key="fpage">13342</infon><infon key="lpage">13349</infon><infon key="name_0">surname:Liang;given-names:M</infon><infon key="name_1">surname:Garrison;given-names:JC</infon><infon key="pub-id_pmid">1649188</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">266</infon><infon key="year">1991</infon><offset>23744</offset><text>The epidermal growth factor receptor is coupled to a pertussis toxin- sensitive nucleotide regulatory protein in rat hepatocytes.</text></passage><passage><infon key="fpage">1369</infon><infon key="lpage">1376</infon><infon key="name_0">surname:Crouch;given-names:MF</infon><infon key="name_1">surname:Belford;given-names:DA</infon><infon key="name_2">surname:Milburn;given-names:PJ</infon><infon key="name_3">surname:Hendry;given-names:IA</infon><infon key="pub-id_pmid">2108675</infon><infon key="section_type">REF</infon><infon key="source">Biochem Biophys Res Commun</infon><infon key="type">ref</infon><infon key="volume">167</infon><infon key="year">1990</infon><offset>23874</offset><text>Pertussis toxin inhibits EGF-, phorbol ester- and insulin-stimulated DNA synthesis in BALB/c3T3 cells: evidence for post-receptor activation of Gi&#945;.</text></passage><passage><infon key="fpage">33202</infon><infon key="lpage">33205</infon><infon key="name_0">surname:Takesono;given-names:A</infon><infon key="name_1">surname:Cismowski;given-names:MJ</infon><infon key="name_2">surname:Ribas;given-names:C</infon><infon key="name_3">surname:Bernard;given-names:M</infon><infon key="name_4">surname:Chung;given-names:P</infon><infon key="name_5">surname:Hazard;given-names:S</infon><infon key="name_6">surname:Duzic;given-names:E</infon><infon key="name_7">surname:Lanier;given-names:SM</infon><infon key="pub-id_doi">10.1074/jbc.274.47.33202</infon><infon key="pub-id_pmid">10559191</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">274</infon><infon key="year">1999</infon><offset>24027</offset><text>Receptor-independent activators of heterotrimeric G-protein signaling pathways.</text></passage><passage><infon key="fpage">13</infon><infon key="lpage">20</infon><infon key="name_0">surname:Thoresen;given-names:GH</infon><infon key="name_1">surname:Johansen;given-names:EJ</infon><infon key="name_2">surname:Christoffersen;given-names:T</infon><infon key="pub-id_doi">10.1006/cbir.1998.0314</infon><infon key="pub-id_pmid">10527544</infon><infon key="section_type">REF</infon><infon key="source">Cell Biol Int</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">1999</infon><offset>24107</offset><text>Effects of cAMP on ERK mitogen-activated protein kinase activity in hepatocytes do not parallell the bidirectional regulation of DNA synthesis.</text></passage><passage><infon key="fpage">1395</infon><infon key="lpage">1401</infon><infon key="name_0">surname:Jo;given-names:H</infon><infon key="name_1">surname:Sipos;given-names:K</infon><infon key="name_2">surname:Go;given-names:Y-M</infon><infon key="name_3">surname:Law;given-names:R</infon><infon key="name_4">surname:Rong;given-names:J</infon><infon key="name_5">surname:McDonald;given-names:JM</infon><infon key="pub-id_doi">10.1074/jbc.272.2.1395</infon><infon key="pub-id_pmid">8995450</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">272</infon><infon key="year">1997</infon><offset>24251</offset><text>Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells.</text></passage><passage><infon key="fpage">418</infon><infon key="lpage">420</infon><infon key="name_0">surname:Crespo;given-names:P</infon><infon key="name_1">surname:Xu;given-names:N</infon><infon key="name_2">surname:Simonds;given-names:WF</infon><infon key="name_3">surname:Gutkind;given-names:S</infon><infon key="pub-id_doi">10.1038/369418a0</infon><infon key="pub-id_pmid">8196770</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">369</infon><infon key="year">1994</infon><offset>24376</offset><text>Ras-dependent activation of MAP kinase pathways mediated by G-protein &#947; subunits.</text></passage><passage><infon key="fpage">7851</infon><infon key="lpage">7854</infon><infon key="name_0">surname:Faure;given-names:M</infon><infon key="name_1">surname:Voyno-Yasenetskaya;given-names:TA</infon><infon key="name_2">surname:Bourne;given-names:HR</infon><infon key="pub-id_pmid">8132501</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">269</infon><infon key="year">1994</infon><offset>24462</offset><text>cAMP and &#947; subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells.</text></passage><passage><infon key="fpage">781</infon><infon key="lpage">784</infon><infon key="name_0">surname:van Biesen;given-names:T</infon><infon key="name_1">surname:Hawes;given-names:B</infon><infon key="name_2">surname:Luttrell;given-names:DK</infon><infon key="name_3">surname:Krueger;given-names:KM</infon><infon key="name_4">surname:Touhara;given-names:K</infon><infon key="name_5">surname:Porfiri;given-names:E</infon><infon key="name_6">surname:Sakaue;given-names:M</infon><infon key="name_7">surname:Luttrell;given-names:LM</infon><infon key="name_8">surname:Lefkowitz;given-names:RJ</infon><infon key="pub-id_doi">10.1038/376781a0</infon><infon key="pub-id_pmid">7651538</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">376</infon><infon key="year">1995</infon><offset>24586</offset><text>Receptor-tyrosine-kinase and G &#947;-mediated MAP kinase activation by a common signaling pathway.</text></passage><passage><infon key="fpage">19992</infon><infon key="lpage">20001</infon><infon key="name_0">surname:Hedin;given-names:KE</infon><infon key="name_1">surname:Bell;given-names:MP</infon><infon key="name_2">surname:Huntoon;given-names:CJ</infon><infon key="name_3">surname:Karnitz;given-names:LM</infon><infon key="name_4">surname:McKean;given-names:DJ</infon><infon key="pub-id_doi">10.1074/jbc.274.28.19992</infon><infon key="pub-id_pmid">10391949</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">274</infon><infon key="year">1999</infon><offset>24685</offset><text>i proteins use a novel &#947;- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes.</text></passage><passage><infon key="fpage">29</infon><infon key="lpage">83</infon><infon key="name_0">surname:Seglen;given-names:PO</infon><infon key="pub-id_pmid">177845</infon><infon key="section_type">REF</infon><infon key="source">Methods Cell Biol</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1976</infon><offset>24858</offset><text>Preparation of isolated rat liver cells.</text></passage><passage><infon key="fpage">217</infon><infon key="lpage">226</infon><infon key="name_0">surname:Christoffersen;given-names:T</infon><infon key="name_1">surname:Refsnes;given-names:M</infon><infon key="name_2">surname:Br&#248;nstad;given-names:GO</infon><infon key="name_3">surname:&#216;stby;given-names:E</infon><infon key="name_4">surname:Huse;given-names:J</infon><infon key="name_5">surname:Haffner;given-names:F</infon><infon key="name_6">surname:Sand;given-names:TE</infon><infon key="name_7">surname:Hunt;given-names:NH</infon><infon key="name_8">surname:Sonne;given-names:O</infon><infon key="pub-id_pmid">6321168</infon><infon key="section_type">REF</infon><infon key="source">Eur J Biochem</infon><infon key="type">ref</infon><infon key="volume">138</infon><infon key="year">1984</infon><offset>24899</offset><text>Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone.</text></passage><passage><infon key="fpage">10131</infon><infon key="lpage">10135</infon><infon key="name_0">surname:Anderson;given-names:NG</infon><infon key="name_1">surname:Kilgour;given-names:E</infon><infon key="name_2">surname:Sturgill;given-names:TW</infon><infon key="pub-id_pmid">1709925</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">266</infon><infon key="year">1991</infon><offset>25073</offset><text>Activation of mitogen-activated protein kinase in BC3H1 myocytes by fluoroaluminate.</text></passage><passage><infon key="fpage">14241</infon><infon key="lpage">14249</infon><infon key="name_0">surname:Jones;given-names:DT</infon><infon key="name_1">surname:Reed;given-names:RR</infon><infon key="pub-id_pmid">2820999</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">262</infon><infon key="year">1987</infon><offset>25158</offset><text>Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium.</text></passage><passage><infon key="fpage">9636</infon><infon key="lpage">9641</infon><infon key="name_0">surname:Aurup;given-names:H</infon><infon key="name_1">surname:Williams;given-names:DM</infon><infon key="name_2">surname:Eckstein;given-names:F</infon><infon key="pub-id_pmid">1390741</infon><infon key="section_type">REF</infon><infon key="source">Biochemistry</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1992</infon><offset>25253</offset><text>2'-fluoro- and 2'-amino-2'deoxynucleoside 5'- triphosphates as substrates for T7 RNA polymerase.</text></passage></document></collection>